content

Japan tops CPhI API Quality ranking for second year

CPhI Japan 2022 returns as a SMART event โ€“ with live exhibition at the Big Sight Exhibition Center in Tokyo (20-22 April) alongside an...

UK Regulator Cites CluePoints Solutions in Updated Guidance

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has been cited in the updated Good...

Studying Clinical Decision Support Systems In Mental Illness

Researchers, in a new study, showed that using a clinical decision support system that stimulates doctors to provide personalised informational handouts about a patient's...

Researchers Take Steps In Developing Regenerated Bone Tissue

According to an announcement made on February 15, 2022, McGill University researchers adoptedย the Canadian Light Source (CLS) at the University of Saskatchewan to create...

Novo Nordisk expands research collaboration in novel delivery technologies for biologic medicines

Novo Nordisk announced the expansion of its existing research collaboration in oral drug delivery technologies with the Massachusetts Institute of Technology (MIT) and Brigham...

Oragenics Engages KBI Biopharma to Support Development of Intranasal COVID-19 Vaccine Candidate NT-CoV2-1

Oragenics, Inc. announced it has entered into an agreement with KBI Biopharma, Inc. for the process transfer, process optimization and cGMP manufacturing of the...

WuXi ATU Announces Launch of TESSA Technology to Improve Scalability and Accessibility of Cell and Gene Therapies

WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, announced the launch of Tetracycline-Enabled Self-Silencing Adenovirus (TESSAโ„ข). This technology is a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read